Ireland· IE-PA-EU/1/22/1674/002
Vyvgart 1000 mg solution for injection
A efgartigimod alfa product containing efgartigimod alfa, registered in Ireland by Argenx. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Efgartigimod alfa is registered in 4 of 19 countries.
Countries holding a registration under ATC L04AA58 (efgartigimod alfa), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Efgartigimod alfa · ATC L04AA58
4 / 19 countries
- Belgiumprice
- Canada
- Ireland
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Efgartigimod ALFA
- Manufacturer
- Argenx
- Country
- Ireland (IE)
- ATC code
- L04AA58
- ATC class
- Efgartigimod alfa
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/22/1674/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efgartigimod alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceVYVGART 1000 mg, solution injectableARGENX (BELGIQUE)
- NetherlandsVyvgart 1000 mg oplossing voor injectieargenx BVBA
- SwitzerlandVyvgart 1000 mg/ 5 ml, solution injectable en seringue préremplieargenx Switzerland SA
- CzechiaVYVGARTargenx BV, Gent
- SpainVYVGART 1.000 MG SOLUCION INYECTABLEArgenx B.V.
- FinlandVyvgartArgenx
- PolandVyvgartargenx BV
- BelgiumVyvgart 1000 mgArgenx
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyvgart
- Liechtenstein · Vyvgart
- Norway · Vyvgart
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a1c9e946-7125-4a0b-813e-d7b156a60587 GET /v1/drugs/a1c9e946-7125-4a0b-813e-d7b156a60587?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"L04AA58"
],
"strength": null,
"pa_number": "EU/1/22/1674/002",
"substances": [
"Efgartigimod ALFA"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "15/11/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about efgartigimod alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.